Citations 1
A Prospective Analysis of High-Dose Interleukin-2 (HD IL-2) following PD-1 inhibitor therapy in patients with metastatic melanoma and renal cell carcinoma.
Buchbinder, Elizabeth I. , Perritt, Jessica, Clark, Joseph I. , Curti, Brendan D. , Lao, Christopher D., Fishman, Mayer , Dutcher, Janice P. , Holtan, Shernan G. , Kirkwood, John M. , Kaufman, Howard L. , McDermott, David F.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21006-e21006
